MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study

MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study

Background and purpose: MRI-guided radiotherapy (MRIgRT) offers multiple potential advantages over CT-guidance. This study examines the potential clinical benefits of MRIgRT for men with localised prostate cancer, in the setting of moderately hypofractionated radiotherapy. We evaluate two-year toxic...

Full description

Bibliographic Details
Main Authors: Kobika Sritharan, Lois Daamen, Angela Pathmanathan, Tine Schytte, Floris Pos, Ananya Choudhury, Jochem R.N. van der Voort van Zyp, Linda G.W. Kerkmeijer, William Hall, Emma Hall, Helena M. Verkooijen, Trina Herbert, Shaista Hafeez, Adam Mitchell, Alison C. Tree
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Clinical and Translational Radiation Oncology
Subjects:
MR-Linac
Prostate cancer
MRIgRT
MOMENTUM
Adaptive radiotherapy
Patient-reported outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630824000193

Similar Items

Similar Items